New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
15:30 EDTWFT, TSCO, SKX, CTXS, NXPI, ETFC, ORLY, CCI, FB, AVB, GILD, T, TRIP, ILMN, QCOMNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include AT&T (T), consensus 63c; Facebook (FB), consensus 32c; QUALCOMM (QCOM), consensus $1.22; Gilead (GILD), consensus $1.79; Crown Castle (CCI), consensus $1.01; Illumina (ILMN), consensus 51c; Avalonbay (AVB), consensus $1.66; O'Reilly Automotive (ORLY), consensus $1.85; TripAdvisor (TRIP), consensus 61c; Citrix (CTXS), consensus 61c; Tractor Supply (TSCO), consensus 95c; E*TRADE (ETFC), consensus 23c; Skechers (SKX), consensus 40c; Weatherford International (WFT), consensus 21c; NXP Semiconductors (NXPI), consensus $1.06
News For T;FB;QCOM;GILD;CCI;ILMN;AVB;ORLY;TRIP;CTXS;TSCO;ETFC;SKX;WFT;NXPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 >>
August 21, 2015
12:14 EDTFBStocks with call strike movement; FB NFLX
Facebook (FB) November 110 call option implied volatility increased 8% to 38, Netflix (NFLX) December 130 call option implied volatility increased 4% to 54 according to iVolatility.
11:12 EDTFB, QCOMQualcomm reportedly to enter consumer drone market
Subscribe for More Information
10:50 EDTQCOMCitron says next stop $70 for shares of Ambarella
Subscribe for More Information
10:43 EDTFBFacebook falls, breaks support at $90
The stock was last at $87.36, down over 3.4%. Support at the $90 level has been broken as well as the 50-day moving average at $90.52, which was uptrend support. At current price next support is at $86. Resistance is at $90.
09:34 EDTFBActive equity options trading on open
Active equity options trading on open: AAPL FB BAC NFLX DIS TSLA TWTR
09:19 EDTQCOMQualcomm to enter consumer drone market, Re/code reports
Subscribe for More Information
08:00 EDTSKXSkechers announces three-for-one stock split subject to investor approval
SKECHERS USA announced that its Board of Directors has approved a three-for-one split of the Company's Class A and Class B common stock that will be distributed in the form of a stock dividend. The stock split is subject to stockholder approval of an amendment to the Company's Certificate of Incorporation to increase the authorized number of Class A and Class B shares. The stockholder vote is expected to take place at a special meeting of stockholders currently scheduled for September 24, 2015. If the Company's stockholders approve the authorization of additional shares, the stock dividend will be distributed to the stockholders of record as of the close of business on October 2, 2015, with a payment date of October 15, 2015. "Our decision to adopt this stock split is another indication of our confidence in our business model worldwide, which we believe will continue to generate profitable growth and strong cash flows," stated Robert Greenberg, Skechers CEO. "We are looking forward to continuing to deliver our broad-based collection of men's, women's and kids' footwear to the global market. Personally, I have never been more confident and excited about the future of Skechers."
05:47 EDTFBStocks with implied volatility movement; NFLX FB
Subscribe for More Information
August 20, 2015
19:35 EDTFBGoogle tests video ads in search results, Digiday says
Subscribe for More Information
16:34 EDTGILDGilead MAA for HIV regimen has been fully validated by EMA
Gilead Sciences announced that the company's Marketing Authorization Application, MAA, for an investigational, once-daily single tablet regimen that combines emtricitabine 200 mg, tenofovir alafenamide 25 mg and rilpivirine 25 mg has been fully validated and is now under evaluation by the European Medicines Agency, EMA. Emtricitabine and tenofovir alafenamide are marketed by Gilead Sciences and rilpivirine is marketed by Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The data included in the application support the use of R/F/TAF for the treatment of HIV-1 infection in adults and pediatric patients 12 years and older. "With this validation, R/F/TAF is now the third TAF-based filing under review by the EMA as we advance a portfolio of new treatment options that may offer high efficacy and favorable safety profiles," said Norbert Bischofberger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer, Gilead Sciences. "The R/F/TAF filing also represents the next step in our collaboration with Janssen to develop HIV treatments that potentially meet the diverse needs of people living with HIV."
16:00 EDTFBOptions Update; August 20, 2015
iPath S&P 500 VIX Short-Term Futures up 1.49 to 17.70. Option volume leaders: AAPL BAC FB NFLX DIS INTC BABA MU
12:56 EDTFBSmall drones bringing air traffic problems in U.S., Washington Post reports
Subscribe for More Information
11:16 EDTFBStocks with call strike movement; FB NFLX
Subscribe for More Information
10:32 EDTFBFacebook August calls active
Facebook August 94 & 95 calls are active on total call volume of 84K contracts (36K puts). August call option implied volatility is at 41, August weekly is at 33, September is at 30; compared to its 52-week range of 20 to 48. Active call volume suggests traders taking positions for upside price movement.
10:00 EDTAVBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:36 EDTFBActive equity options trading on open
Subscribe for More Information
08:02 EDTTFCC to hold a conference and workshop
2015 Supplier Diversity Conference & Workshop is being held at FCC Washington, D.C. offices on August 20 at 9:30 am. Webcast Link
07:50 EDTNXPINXP Semiconductors management to meet with SunTrust
Meetings to be held in Dallas/Houston on August 26, in Houston/Denver on August 27 and in Los Angeles on August 28 hosted by SunTrust.
06:45 EDTSKXSkechers volatility increases as shares near record high
Skechers August call option implied volatility is at 40, September is at 36; compared to its 52-week range of 27 to 58, suggesting non-directional price movement.
06:34 EDTAVBAvalonBay upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use